Lime Global Ltd, the UK’s leading provider of online-only affordable and accessible digital healthcare top-ups, has raised £474,838 from 209 investors via crowdfunding platform, Seedrs – exceeding its initial target of £400,000 at 117%. 

Seneca Partners, the specialist SME investment business based in the North West, has invested £1.2m into biotech company, SolasCure to support the development of their wound cleaning product, Aurase® through the Seneca EIS Portfolio Service and Seneca Growth Capital VCT.  Seneca’s investment comes as SolasCure is developing proprietary technology leveraging biomimicry and evidence-based medicine to empower health care professionals to treat patients with chronic wounds. 

Walking on Earth is coming out of stealth to tackle the rising issue of workplace stress exacerbated by the COVID pandemic and remote working. The digital platform has closed a £3 million seed funding round led by Octopus Ventures, which supported success stories such as Cazoo, Depop and Graze. Walking on Earth benefits from further backing from renowned UK founders.

Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout investments, has entered into an agreement to sell its stake in Demetra Holding S.p.A. to Astorg.

Maven Capital Partners, one of the UK’s most active private equity houses, has invested a further £500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional £17 million gross and listing on AIM with a market capitalisation of £42.2 million.

Vira Health, a digital health company focused on improving long-term health for women, has raised £1.5M in seed funding from LocalGlobe, MMC Ventures, and angel investors including Megumi Ikeda, Managing Director, Hearst Ventures, Andrea Zitna of Elvie, former Spotify executive Sofia Bendz, founder of GoCardless Matt Robinson, and Simon Lambert, former CTO, MOO.com, and Treatwell. 

Peppy, a B2B digital health platform, has announced a £6.6m Series A funding round. Peppy provides tailored, expert-led support to individuals before they need to see a doctor, bridging the gap between online searches and hard-to-access clinical care. The investment was led by Felix Capital with previous investors including Outward VC, Seedcamp, and Hambro Perks, also participating. 

4D Biomaterials, a medtech company which has developed a new biomaterial used for 3D printing medical implants, has completed a £1.6m funding round led by DSW Ventures.

Patchwork Health, the healthcare staffing platform founded by doctors, has raised £3.5m to accelerate their mission to solve the NHS burnout crisis. The funding, from Praetura Ventures and BMJ New Ventures, comes as an NHS workforce 'emergency' is declared and waiting lists reach record highs.

Leo Cancer Care is an innovative start-up company that is set to change the face of Radiation Therapy forever. They recently completed their Series B fundraising activities, through parent company Asto CT Inc. alongside the team at Pureland Global Venture. The fundraise has seen investments from investors located all across the globe, some of the largest investors in the fundraise alongside Pureland were investment companies Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.

Calculus Capital and Foresight Group have successfully sold Mologic Limited, a world leading innovator in lateral flow and rapid diagnostic technologies, and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.

Foresight Group LLP, an award-winning listed infrastructure and regional private equity investment manager, has sold Mologic Limited, a World leading innovator in lateral flow and rapid diagnostic technologies and founder of Global Access Diagnostics. Mologic’s co-founder and Chief Scientific Officer, Paul Davis, was the originator of the Clearblue pregnancy test, the world’s first commercial application of lateral flow technology.